Skip to main content
OpenTrials
Completed

NCT Number: NCT02104089

Post-market Observational Study Zenith® t-Branch™

The Zenith® t-Branch™ Thoracoabdominal Endovascular Graft Study is a post-market observational study to evaluate the performance of the Zenith® t-Branch™ in the treatment of thoracoabdominal aortic aneurysms in routine care.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

Universitäts Krankenhaus Eppendorf, Hamburg, Germany

Loading trial locations.

About this study

Both retrospective and prospective patients will be enrolled

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Treated with the off-the-shelf Zenith® t-Branch™ Thoracoabdominal Endovascular Graft
  • Signed informed consent

Exclusion criteria

  • Inability or refusal to give informed consent by the patient or a legally authorized representative

Treatment and study plan

Zenith® t-Branch™ Thoracoabdominal Endovascular Graft

Device

Instead of making a large incision in the chest, the physician makes a small incision near each hip to insert, and guide the study device(s) into place in the aorta.

Primary outcomes

  1. Rate of mortality and morbidity

    Time frame: 30 days

Sponsors and collaborators

Lead sponsor

Cook Group Incorporated

Industry

Registry information

Official study title

Post-market Observational Study Zenith® t-Branch™ Thoracoabdominal Endovascular Graft

Important dates

Study start
2014
Primary completion
2017
Study completion
2020
First posted
Apr 4, 2014
Registry last updated
Jan 27, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.